← Leaderboards
Mark L Kahn
University Of Pennsylvania
$46,704,160
Attributed
$50,226,453
Total exposure
27
Grants
26
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$50,226,453 · 27
By mechanism
R01$41,733,222 · 18
P01$7,542,212 · 5
R21$433,125 · 1
S10$256,390 · 1
K08$240,894 · 1
R13$20,610 · 1
Top collaborators
- Igor E Brodsky5 shared
- Edward E Morrisey5 shared
- Wolfgang Bergmeier4 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Chinmay M Trivedi$8,768,083
- David Richard Enis$500,812
- Vera P Krymskaya$16,207,847
- Charles S Abrams$21,618,471
- Martha S Jordan$4,688,068
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionMolecularIn VivoBlood VesselsPathway InteractionsGeneticCellsPhenotypeAnimalsEndothelial CellsInsightPreventPathogenesisProteinsEmbryoSignal PathwayGene ExpressionResponseBloodEndotheliumRegulationLymphaticGenesMediating
Grant awards (117)
Genetic Investigation of Covid 19 in Lung Disease$904,852
R01 · FY2025 · HL · contact PI
Mechanical regulation of cardiac growth and remodeling by VCAN-GPR126 signaling$744,692
R01 · FY2025 · HL · contact PI
VEGFR1 and its regulation by thrombin signaling during placental vascular growth$722,824
R01 · FY2025 · HL · contact PI
Reciprocal VEGFC/VEGFR3-CDH5 regulation of lymphatic and sinusoidal vascular growth$614,429
R01 · FY2025 · HL · contact PI
Genetic Investigation of Covid 19 in Lung Disease$869,001
R01 · FY2024 · HL · contact PI
Reciprocal VEGFC/VEGFR3-CDH5 regulation of lymphatic and sinusoidal vascular growth$602,142
R01 · FY2024 · HL · contact PI
Downstream molecular mechanisms underlying cerebral cavernous malformation$296,731
P01 · FY2024 · NS · contact PI
Genetic Investigation of Covid 19 in Lung Disease$908,674
R01 · FY2023 · HL · contact PI
Flow and endothelial signaling in acquired myxomatous valve disease$702,994
R01 · FY2023 · HL · contact PI
Reciprocal VEGFC/VEGFR3-CDH5 regulation of lymphatic and sinusoidal vascular growth$606,304
R01 · FY2023 · HL · contact PI
Lymphothrombosis in gut health and disease$406,250
R01 · FY2023 · DK · contact PI
Downstream molecular mechanisms underlying cerebral cavernous malformation$308,832
P01 · FY2023 · NS · contact PI
Genetic Investigation of Covid 19 in Lung Disease$168,935
R01 · FY2023 · HL · contact PI
Genetic Investigation of Covid 19 in Lung Disease$922,822
R01 · FY2022 · HL · contact PI
Flow and endothelial signaling in acquired myxomatous valve disease$717,180
R01 · FY2022 · HL · contact PI
Reciprocal VEGFC/VEGFR3-CDH5 regulation of lymphatic and sinusoidal vascular growth$598,179
R01 · FY2022 · HL · contact PI
Lymphothrombosis in gut health and disease$406,250
R01 · FY2022 · DK · contact PI
Downstream molecular mechanisms underlying cerebral cavernous malformation$311,790
P01 · FY2022 · NS · contact PI
MEKK3 signaling in hemogenic endothelium$760,835
R01 · FY2021 · HL · contact PI
Flow and endothelial signaling in acquired myxomatous valve disease$722,814
R01 · FY2021 · HL · contact PI
Molecular and genetic basis of deep venous thrombosis$584,332
R01 · FY2021 · HL · contact PI
TLR4 and the microbiome in CCM disease$539,561
R01 · FY2021 · NS · contact PI
Lymphothrombosis in gut health and disease$406,250
R01 · FY2021 · DK · contact PI
Molecular and genetic basis of deep venous thrombosis$358,790
R01 · FY2021 · HL · contact PI
Downstream molecular mechanisms underlying cerebral cavernous malformation$314,670
P01 · FY2021 · NS · contact PI
MEKK3 signaling in hemogenic endothelium$760,835
R01 · FY2020 · HL · contact PI
Flow and endothelial signaling in acquired myxomatous valve disease$725,845
R01 · FY2020 · HL · contact PI
Molecular and genetic basis of deep venous thrombosis$590,337
R01 · FY2020 · HL · contact PI
TLR4 and the microbiome in CCM disease$565,713
R01 · FY2020 · NS · contact PI
Molecular and genetic basis of deep venous thrombosis$420,273
R01 · FY2020 · HL · contact PI
Lymphothrombosis in gut health and disease$405,000
R01 · FY2020 · DK · contact PI
Downstream molecular mechanisms underlying cerebral cavernous malformation$322,231
P01 · FY2020 · NS · contact PI
MEKK3 signaling in hemogenic endothelium$807,159
R01 · FY2019 · HL · contact PI
Molecular and genetic basis of deep venous thrombosis$600,419
R01 · FY2019 · HL · contact PI
TLR4 and the microbiome in CCM disease$565,713
R01 · FY2019 · NS · contact PI
Lymphothrombosis in gut health and disease$405,000
R01 · FY2019 · DK · contact PI
MEKK3-ERK5-KLF signaling in CCM pathogenesis$286,441
P01 · FY2019 · NS · contact PI
MEKK3 signaling in hemogenic endothelium$829,654
R01 · FY2018 · HL · contact PI
Molecular and genetic basis of deep venous thrombosis$709,626
R01 · FY2018 · HL · contact PI
TLR4 and the microbiome in CCM disease$574,326
R01 · FY2018 · NS · contact PI
Investigation of a Novel Tissue-specific Mechanism of Hemostasis$407,200
P01 · FY2018 · HL · contact PI
Genetic Investigation of pulmonary lymphatic development and function$400,864
R01 · FY2018 · HL · contact PI
Heg-CCM Signaling in Cardiovascular Development and Disease$400,000
R01 · FY2018 · HL · contact PI
MEKK3-ERK5-KLF signaling in CCM pathogenesis$286,441
P01 · FY2018 · NS · contact PI
TLR4 and the microbiome in CCM disease$600,761
R01 · FY2017 · NS · contact PI
Investigation of a Novel Tissue-specific Mechanism of Hemostasis$407,200
P01 · FY2017 · HL · contact PI
Genetic Investigation of pulmonary lymphatic development and function$400,832
R01 · FY2017 · HL · contact PI
Heg-CCM Signaling in Cardiovascular Development and Disease$400,000
R01 · FY2017 · HL · contact PI
Spatial regulation of platelet activation by Podoplanin-Clec2 signaling$303,806
R01 · FY2017 · HL · contact PI
MEKK3-ERK5-KLF signaling in CCM pathogenesis$300,668
P01 · FY2017 · NS · contact PI
2017 Vascular Cell Biology Gordon Research Conference & Gordon Research Seminar$20,610
R13 · FY2017 · HL · contact PI
Investigation of a Novel Tissue-specific Mechanism of Hemostasis$406,922
P01 · FY2016 · HL · contact PI
Genetic Investigation of pulmonary lymphatic development and function$400,803
R01 · FY2016 · HL · contact PI
Role of CCBE1 in lymphatic vascular development and growth$400,000
R01 · FY2016 · HL · contact PI
Heg-CCM Signaling in Cardiovascular Development and Disease$400,000
R01 · FY2016 · HL · contact PI
Spatial regulation of platelet activation by Podoplanin-Clec2 signaling$305,909
R01 · FY2016 · HL · contact PI
MEKK3-ERK5-KLF signaling in CCM pathogenesis$305,416
P01 · FY2016 · NS · contact PI
Investigation of a Novel Tissue-specific Mechanism of Hemostasis$400,443
P01 · FY2015 · HL · contact PI
Heg-CCM Signaling in Cardiovascular Development and Disease$400,000
R01 · FY2015 · HL · contact PI
Genetic Investigation of pulmonary lymphatic development and function$394,755
R01 · FY2015 · HL · contact PI
Role of CCBE1 in lymphatic vascular development and growth$394,000
R01 · FY2015 · HL · contact PI
MEKK3-ERK5-KLF signaling in CCM pathogenesis$320,165
P01 · FY2015 · NS · contact PI
Spatial regulation of platelet activation by Podoplanin-Clec2 signaling$304,837
R01 · FY2015 · HL · contact PI
Molecular mechanisms of CCM signaling$517,616
R01 · FY2014 · HL · contact PI
Investigation of a Novel Tissue-specific Mechanism of Hemostasis$422,200
P01 · FY2014 · HL · contact PI
Genetic Investigation of pulmonary lymphatic development and function$415,738
R01 · FY2014 · HL · contact PI
Role of CCBE1 in lymphatic vascular development and growth$392,000
R01 · FY2014 · HL · contact PI
Spatial regulation of platelet activation by Podoplanin-Clec2 signaling$327,000
R01 · FY2014 · HL · contact PI
Molecular mechanisms of CCM signaling$502,827
R01 · FY2013 · HL · contact PI
Role of CCBE1 in lymphatic vascular development and growth$400,000
R01 · FY2013 · HL · contact PI
Control of lymphatic vessel growth and development by platelets$376,992
R01 · FY2013 · HL · contact PI
Heg-CCM Signaling in Cardiovascular Development and Disease$371,102
R01 · FY2013 · HL · contact PI
Vevo 2100 Imaging System$256,390
S10 · FY2013 · OD · contact PI
Molecular mechanisms of CCM signaling$528,179
R01 · FY2012 · HL · contact PI
Control of lymphatic vessel growth and development by platelets$396,000
R01 · FY2012 · HL · contact PI
Heg-CCM Signaling in Cardiovascular Development and Disease$389,813
R01 · FY2012 · HL · contact PI
Molecular mechanisms of CCM signaling$528,179
R01 · FY2011 · HL · contact PI
Control of lymphatic vessel growth and development by platelets$400,000
R01 · FY2011 · HL · contact PI
Heg-CCM Signaling in Cardiovascular Development and Disease$393,750
R01 · FY2011 · HL · contact PI
Regulation of Angiogenesis by SLP-76 Signaling$393,750
R01 · FY2011 · HL · contact PI
Molecular mechanisms of CCM signaling$569,660
R01 · FY2010 · HL · contact PI
Control of lymphatic vessel growth and development by platelets$400,000
R01 · FY2010 · HL · contact PI
Heg-CCM Signaling in Cardiovascular Development and Disease$393,750
R01 · FY2010 · HL · contact PI
Regulation of Angiogenesis by SLP-76 Signaling$393,750
R01 · FY2010 · HL · contact PI
Regulation of vascular development and function by LKLF$382,331
R01 · FY2010 · HL · contact PI
Genetic investigation of Notch signaling in lymphatic endothelium$275,625
R21 · FY2010 · HL · contact PI
Heg-CCM Signaling in Cardiovascular Development and Disease$393,750
R01 · FY2009 · HL · contact PI
Regulation of Angiogenesis by SLP-76 Signaling$393,750
R01 · FY2009 · HL · contact PI
Regulation of vascular development and function by LKLF$382,331
R01 · FY2009 · HL · contact PI
Genetic investigation of Notch signaling in lymphatic endothelium$157,500
R21 · FY2009 · HL · contact PI
Regulation of Angiogenesis by SLP-76 Signaling$393,750
R01 · FY2008 · HL · contact PI
Regulation of vascular development and function by LKLF$382,331
R01 · FY2008 · HL · contact PI
ROLE OF SYK IN LYMPHATIC VASCULAR DEVELOPMENT$333,077
P01 · FY2008 · HL · contact PI
CORE C- HISTOLOGY AND GENE EXPRESSION$318,036
P01 · FY2008 · HL · contact PI
Regulation of vascular development and function by LKLF$382,331
R01 · FY2007 · HL · contact PI
Regulation of angiogenesis by SLP-76 signaling$375,716
R01 · FY2007 · HL · contact PI
ROLE OF SYK IN LYMPHATIC VASCULAR DEVELOPMENT$331,710
P01 · FY2007 · HL · contact PI
CORE C- HISTOLOGY AND GENE EXPRESSION$315,796
P01 · FY2007 · HL · contact PI
Regulation of vascular development and function by LKLF$392,500
R01 · FY2006 · HL · contact PI
Regulation of angiogenesis by SLP-76 signaling$386,938
R01 · FY2006 · HL · contact PI
Collagen signaling in platelets$348,245
R01 · FY2006 · HL · contact PI
ROLE OF SYK IN LYMPHATIC VASCULAR DEVELOPMENT$203,276
P01 · FY2006 · HL · contact PI
CORE C- HISTOLOGY AND GENE EXPRESSION$192,752
P01 · FY2006 · HL · contact PI
Regulation of angiogenesis by SLP-76 signaling$396,250
R01 · FY2005 · HL
Collagen signaling in platelets$356,625
R01 · FY2005 · HL
ROLE OF SYK IN LYMPHATIC VASCULAR DEVELOPMENT$198,474
P01 · FY2005 · HL
CORE C- HISTOLOGY AND GENE EXPRESSION$187,428
P01 · FY2005 · HL
Collagen signaling in platelets$400,543
R01 · FY2004 · HL
Regulation of angiogenesis by SLP-76 signaling$396,250
R01 · FY2004 · HL
CORE C- HISTOLOGY AND GENE EXPRESSION$182,260
P01 · FY2004 · HL
ROLE OF SYK IN LYMPHATIC VASCULAR DEVELOPMENT$182,053
P01 · FY2004 · HL
Collagen signaling in platelets$35,398
R01 · FY2004 · HL
Regulation of angiogenesis by SLP-76 signaling$396,250
R01 · FY2003 · HL
Collagen signaling in platelets$356,625
R01 · FY2003 · HL
Collagen signaling in platelets$356,625
R01 · FY2002 · HL
IN VIVO ANALYSIS OF PROTEASE ACTIVATED RECEPTORS$120,447
K08 · FY2001 · HL
IN VIVO ANALYSIS OF PROTEASE ACTIVATED RECEPTORS$120,447
K08 · FY2000 · HL